Related references
Note: Only part of the references are listed.Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop
Patricia L. M. Dahia et al.
ENDOCRINE-RELATED CANCER (2020)
The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature
Adam Stenman et al.
CANCERS (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
SDHB mutation carriers with malignant pheochromocytoma respond better to CVD
L. Fishbein et al.
ENDOCRINE-RELATED CANCER (2017)
Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma
Jung-Min Koh et al.
PLOS ONE (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis
Oksana Hamidi et al.
CLINICAL ENDOCRINOLOGY (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
SDHD Immunohistochemistry: A New Tool to Validate SDHx Mutations in Pheochromocytoma/Paraganglioma
Melanie Menara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G. Papathomas et al.
MODERN PATHOLOGY (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
Noriko Kimura et al.
ENDOCRINE-RELATED CANCER (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
NEUROENDOCRINE CANCER Closing the GAPP on predicting metastases
Graeme Eisenhofer et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing
Lauren Fishbein et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Usefulness of Negative and Weak-Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas
Esmeralda Castelblanco et al.
ENDOCRINE PATHOLOGY (2013)
Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing
Joakim Crona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
Graeme Eisenhofer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics
P. -F. Plouin et al.
HORMONE AND METABOLIC RESEARCH (2012)
Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas
Jenny Welander et al.
HUMAN MOLECULAR GENETICS (2012)
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2012)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
Montserrat Ayala-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
Anthony J. Gill et al.
HUMAN PATHOLOGY (2010)
Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score
David Wu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
The diagnosis and management of malignant phaeochromocytoma and paraganglioma
Alexandra Chrisoulidou et al.
ENDOCRINE-RELATED CANCER (2007)
Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms - A clinicopathologic and immunophenotypic study of 100 cases
LDR Thompson
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Share Paper
